financetom
Business
financetom
/
Business
/
Boeing taps debt market to raise $10 billion: sources
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Boeing taps debt market to raise $10 billion: sources
Apr 29, 2024 9:50 AM

April 29 (Reuters) - Boeing ( BA ) on Monday tapped debt

markets to raise $10 billion, after the U.S. planemaker burned

$3.93 billion in free cash during the first quarter following

slowing production of its best-selling jet, sources familiar

with the matter said.

Boeing's ( BA ) credit rating hovered above "junk" status last week

from rating agencies as the planemaker tries to recover from a

crisis that began in January after a midair blowout of a cabin

panel door plug on a nearly new 737 MAX 9.

Investors and analysts have said Boeing ( BA ) could tap bond

markets to get ahead of more than $12 billion in combined debt

coming due in 2025 and 2026.

Credit rating agencies on Monday both assigned ratings

nearing junk to Boeing's ( BA ) new senior unsecured notes, with S&P

assigning a BBB- rating and Moody's assigning a Baa3 rating.

Moody's said the rating reflects Boeing's ( BA ) still-strong

business profile, which continues to mitigate ongoing weak

performance in commercial aircraft, although headwinds

surrounding the division could persist through 2026.

Boeing ( BA ) will use the bond proceeds to increase its liquidity

ahead of maturities on its existing debt load, including $4.3

billion in 2025, S&P wrote on Monday.

"It looks like it will go well," said one of the sources,

who was looking at buying the bonds, adding that he was told it

was eight times oversubscribed.

The deal's bookrunners leading the bond sale include Bank

of America, Citi, JPMorgan and Wells Fargo, according to the

deal's term sheet.

Boeing ( BA ) declined to comment, but pointed to remarks from

Chief Financial Officer Brian West during the company's earnings

last week in which he said Boeing ( BA ) was committed to managing its

balance sheet in a prudent manner, with the goal of prioritizing

its investment-grade rating and helping the factory and supply

chain to stabilize.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TSMC Q2 revenue handily beats market forecasts
TSMC Q2 revenue handily beats market forecasts
Jul 9, 2024
TAIPEI, July 10 (Reuters) - TSMC, the world's largest contract chipmaker, reported on Wednesday second quarter revenue of T$673.51 billion ($20.67 billion), according to Reuters calculations, handily beating market forecasts. An LSEG SmartEstimate, drawn from 21 analysts, predicted second quarter revenue of T$654.27 billion. ($1 = 32.5790 Taiwan dollars) ...
Yokohama Rubber in talks to buy Goodyear's off-road tyre business for at least $1 billion, Bloomberg says
Yokohama Rubber in talks to buy Goodyear's off-road tyre business for at least $1 billion, Bloomberg says
Jul 9, 2024
TOKYO (Reuters) - Japan's Yokohama Rubber ( YORUF ) is in talks to buy Goodyear Tire & Rubber's ( GT ) off-road tyre business for at least $1 billion, Bloomberg reported on Wednesday. Yokohama Rubber's ( YORUF ) shares fell as much as 7% before paring some losses to trade down 4.5% by late trade. Yokohama Rubber ( YORUF )...
TSMC Q2 revenue jumps on AI boost, handily beats market forecasts
TSMC Q2 revenue jumps on AI boost, handily beats market forecasts
Jul 9, 2024
TAIPEI (Reuters) -TSMC, the world's largest contract chipmaker, reported strong growth in second-quarter revenue on Wednesday that handily beat market forecasts, on the back of booming demand for artificial intelligence (AI) applications. Taiwan Semiconductor Manufacturing Co ( TSM ), whose customers include Apple and Nvidia, has benefited from the surge towards AI that has helped it weather the tapering off...
BRIEF-Evotec And Pfizer Collaborate To Advance Drug Discovery In France
BRIEF-Evotec And Pfizer Collaborate To Advance Drug Discovery In France
Jul 9, 2024
July 10 (Reuters) - EVOTEC SE: * EVOTEC AND PFIZER COLLABORATE TO ADVANCE DRUG DISCOVERY IN FRANCE * MULTI-YEAR COLLABORATION WILL INITIALLY FOCUS ON EARLY DISCOVERY RESEARCH FOR METABOLIC AND INFECTIOUS DISEASES * ANNOUNCED IT HAS ENTERED INTO A MULTI-YEAR MASTER RESEARCH COLLABORATION AND OPTION AND LICENSE AGREEMENT WITH PFIZER * EVOTEC AND PFIZER WILL INITIALLY FOCUS ON EARLY DISCOVERY...
Copyright 2023-2026 - www.financetom.com All Rights Reserved